Training activity information

Details

Respond to clinical queries/ significant results related to the diagnosis and management of infection in neonates.

To include selection and interpretation of relevant tests and drafting of advice.

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

  • What specific knowledge about common neonatal pathogens, interpretation of blood culture and other results in neonates, and the importance of rapid turnaround times do you need to review?
  • What specific insights into the critical nature of neonatal infections and the role of the laboratory in their timely diagnosis do you hope to gain? What is your current understanding of the unique aspects of the neonatal immune system?
  • Have you discussed typical clinical queries and significant results related to neonatal infections with your training officer? What challenges might you encounter in interpreting subtle signs or advising on empirical treatment in neonates? How will you approach these? How do you feel about the responsibility of dealing with potentially life-threatening infections in newborns?

In action

  • What are your first steps in addressing the clinical query or significant result for a neonate?
    • What unique vulnerabilities and considerations for this age group are immediately at the forefront of your thinking?
    • What critical decisions are you making regarding the urgent need for investigations, the interpretation of often subtle or non-specific results, and the formulation of immediate management advice for a potentially life-threatening situation?
    • What aspects of dealing with neonatal samples or interpreting neonatal results feel more familiar, and where do you need to be particularly cautious and apply specific neonatal knowledge?
  • How well do you believe your current actions are addressing the urgent diagnostic and management needs of this neonate?
    • What specific difficulties or complexities related to diagnosing and managing infections in newborns are you facing?
    • What are you learning about the rapid and potentially devastating nature of neonatal infections as you engage with this DTA?
    • How does this activity connect to your understanding of neonatal immunology, common neonatal pathogens, and the importance of timely intervention?
  • Are you considering the need for a broad range of investigations and empirical treatment based on the clinical presentation?
    • Do you recognise the absolute necessity for immediate communication and collaboration with neonatology colleagues?
    • Are you ensuring your immediate actions are in line with protocols for suspected serious neonatal infections?

On action

  • Begin by summarising the key points of the experience of responding to clinical queries/significant results for neonates with suspected infections.
  • What skills or knowledge did you develop or improve related to the unique challenges of diagnosing and managing infections in neonates, including interpretation of often subtle clinical signs and specific laboratory markers?
    • Were there any unexpected challenges or successes in providing timely advice for suspected early-onset or late-onset neonatal sepsis? What did you learn from these?
    • In what ways did your reflection-in-action (during the activity) influence your approach to urgent testing and empirical antimicrobial recommendations in this vulnerable population?
    • How does this experience relate to the requirements for post-programme practice in providing expert microbiological advice to neonatal units?
  • What areas for continued development have been identified in responding to clinical queries for neonatal infections?
    • How can you apply the learning from this activity to your routine practice, particularly in understanding neonatal infection guidelines and the importance of rapid communication with neonatal teams?
    • Identify the actions / ‘next steps’ you will now take to support the assimilation of what you have learned, such as reviewing neonatal sepsis guidelines or discussing cases with neonatologists.
    • What support or resources might you need to further develop your skills in this area, such as attending neonatal infection workshops or reviewing relevant research?

Beyond action

  • How has your understanding of managing infections in neonates evolved since undertaking this DTA and gaining further experience?
  • How have you applied the skills and knowledge gained from this DTA regarding test selection, interpretation, and advice drafting for neonates to other vulnerable patient groups or specific neonatal scenarios?
  • What connections can you draw between this DTA and other training activities or clinical experiences, such as attending relevant multidisciplinary team meetings or interpreting neonatal infection aetiology, and how do they build towards your overall development as a Healthcare Scientist dealing with very young patients?
  • What further development needs related to neonatal infections have been identified through revisiting this experience, and what actions will you now take?

Relevant learning outcomes

# Outcome
# 1 Outcome

Identify appropriate investigative strategies to diagnose and manage infections associated with specialist patient groups, considering guidance and public health requirements

# 2 Outcome

Select tests to diagnose and manage infections and interpret the results in the clinical context for specialist patient groups, with consideration of laboratory quality assurance and quality control

# 3 Outcome

Develop plans and provide advice on infection management for specialist patient groups considering infection control, guidelines and public health requirements